Key Compression Therapy Market Players:
- 3M (U.S.)
- Essity Aktiebolag (publ) (Sweden)
- Cardinal Health (U.S.)
- Smith & Nephew plc (UK)
- Paul Hartmann AG (Germany)
- BSN medical (Germany)
- Medtronic plc (Ireland)
- ConvaTec Group PLC (UK)
- Arjo (Sweden)
- SIGVARIS GROUP (Switzerland)
- medi GmbH & Co. KG (Germany)
- Julius Zorn GmbH (Germany)
- DJO Global (U.S.)
- Lohmann & Rauscher (Germany)
- Becton, Dickinson and Company (U.S.)
- Tactile Medical (U.S.)
- Ofa Bamberg (Germany)
- Nitto Denko Corporation (Japan)
- Bio Compression Systems, Inc. (U.S.)
- CONTINENTAL S.r.l. (Italy)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- 3M uses its advanced material science and global commercial footprint. The company’s strategic initiatives focus on integrating its diverse wound care and surgical portfolios to offer comprehensive solutions from cohesive bandages to advanced layered systems. According to the 2024 annual report, the company has made a net sale of USD 11.08 billion.
- As a global hygiene and health leader, Essity holds a commanding position in the compression therapy market via brands such as JOBST and Leukoplast. The company’s strategy emphasizes a holistic approach to compression, combining premium medical compression garments with consumer-centric self-care products. Nearly 20% of the total net sales are from the health and medicine sector in 2024.
- Cardinal Health competes in the compression therapy market primarily via its vast distribution network and portfolio of its own brand medical products. Its strategic initiatives are centered on providing cost-effective, reliable compression solutions to a broad base of healthcare facilities and providers.
- Within the compression therapy market, Smith & Nephew’s strategic focus is on advanced wound management, where compression is a significant component. The company integrates its compression technologies, such as the ACTIVA line, with its advanced wound dressings and negative pressure wound therapy systems.
- Paul Hartmann AG is a key leader in Europe in the compression therapy market, renowned for systems such as the Tensopress and Setopress. The company’s strategy is built on a foundation of high-quality, innovative textile design and a strong commitment to clinical education. Strategic initiatives include developing multi-layer compression kits that simplify correct application for clinicians.
Here is a list of key players operating in the global market:
The global compression therapy market is fragmented, with the dominant multinational med tech corporations competing alongside specialized players. The key strategic initiatives include extensive investment in R&D to develop advanced materials and hybrid pneumatic devices. The market leaders are actively expanding via acquisitions of smaller niche companies and forging distribution partnerships to strengthen the geographic reach, mainly in high-growth emerging markets. For example, in November 2025, Solventum announces an agreement to acquire Acera Surgical. Moreover, a strong focus is on the direct-to-consumer marketing and educational initiatives for both patients and clinicians, which is also prevalent, aiming to drive the adoption of conditions such as lymphedema and chronic venous insufficiency.
Corporate Landscape of the Compression Therapy Market: